| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.44M | 7.39M | 7.32M | 634.42K | 2.01M | 644.00K |
| Gross Profit | 4.22M | 5.05M | 4.52M | -2.76M | -1.98M | -3.24M |
| EBITDA | -3.27M | -6.28M | -3.26M | -4.91M | -4.15M | -5.50M |
| Net Income | -4.05M | -7.40M | -4.17M | -5.44M | -4.90M | -5.51M |
Balance Sheet | ||||||
| Total Assets | 43.05M | 38.78M | 17.35M | 8.84M | 7.86M | 13.41M |
| Cash, Cash Equivalents and Short-Term Investments | 32.19M | 30.48M | 7.87M | 4.59M | 2.99M | 7.26M |
| Total Debt | 2.16M | 1.79M | 2.17M | 348.12K | 549.90K | 540.00K |
| Total Liabilities | 6.70M | 6.69M | 7.36M | 1.91M | 1.23M | 1.88M |
| Stockholders Equity | 36.35M | 32.09M | 9.99M | 6.93M | 6.63M | 11.53M |
Cash Flow | ||||||
| Free Cash Flow | -6.08M | -5.00M | -2.64M | -3.72M | -4.13M | -8.17M |
| Operating Cash Flow | -4.56M | -2.89M | -1.75M | -3.64M | -3.80M | -6.15M |
| Investing Cash Flow | -1.49M | -2.11M | -899.33K | 20.86K | -272.02K | -2.03M |
| Financing Cash Flow | 33.95M | 27.66M | 5.91M | 5.22M | -192.70K | 7.16M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | AU$190.69M | 48.48 | 12.33% | 0.74% | 24.67% | 96.27% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | AU$106.39M | 32.66 | 5.66% | 1.28% | -14.88% | -56.89% | |
56 Neutral | AU$152.60M | -5.46 | -8.21% | ― | 3.30% | -294.63% | |
41 Neutral | AU$104.98M | -11.86 | -35.18% | ― | 0.88% | 4.88% |
AML3D Limited has announced a change in the director’s interest notice, specifically regarding Andrew Michael Clayton Sales. The director has acquired 2,000,000 options exercisable at $0.73 on or before November 20, 2030, with shareholder approval at the AGM. This change reflects a strategic move within the company’s leadership, potentially impacting its market dynamics and shareholder value.
The most recent analyst rating on (AU:AL3) stock is a Hold with a A$0.16 price target. To see the full list of analyst forecasts on AML3D Ltd stock, see the AU:AL3 Stock Forecast page.
AML3D Ltd announced a change in the director’s interest, with Noel Cornish acquiring 2,000,000 unlisted options exercisable at $0.73 on or before November 20, 2030. This change, approved at the AGM, reflects the company’s ongoing strategic efforts to align its leadership’s interests with its long-term growth objectives, potentially impacting its market positioning and stakeholder confidence.
The most recent analyst rating on (AU:AL3) stock is a Hold with a A$0.16 price target. To see the full list of analyst forecasts on AML3D Ltd stock, see the AU:AL3 Stock Forecast page.
AML3D Limited has announced a change in the director’s interest notice, specifically for Director Peter Siebels. The change involves the acquisition of 2,000,000 options exercisable at $0.73 on or before November 20, 2030, with shareholder approval at the AGM. This update reflects a strategic move to align the director’s interests with the company’s long-term goals, potentially impacting the company’s governance and stakeholder confidence.
The most recent analyst rating on (AU:AL3) stock is a Hold with a A$0.16 price target. To see the full list of analyst forecasts on AML3D Ltd stock, see the AU:AL3 Stock Forecast page.
AML3D Ltd has announced a change in the director’s interest, specifically for Director Sean Ebert, who has acquired 2,000,000 unlisted options and 575,929 performance rights. This change in director’s interest reflects adjustments in the company’s internal management and could potentially influence its strategic direction and stakeholder relations.
The most recent analyst rating on (AU:AL3) stock is a Hold with a A$0.16 price target. To see the full list of analyst forecasts on AML3D Ltd stock, see the AU:AL3 Stock Forecast page.
AML3D Limited has secured a significant order worth approximately $1.7 million for its ARCEMY® X system from FasTech LLC, a US-based supplier to the Defense, Aerospace, Energy, and other industrial sectors. This order not only enhances FasTech’s manufacturing capabilities but also strengthens AML3D’s presence in the US market. The ARCEMY® X system will be installed at FasTech’s facility near the U.S. Navy Additive Manufacturing Center of Excellence in Virginia and is expected to be operational by the third quarter of the 2026 financial year. This development is part of AML3D’s strategy to expand its footprint in the US by demonstrating the advantages of its additive manufacturing technology across various industrial sectors, thereby increasing demand for its systems and embedding itself further into the US manufacturing landscape.
The most recent analyst rating on (AU:AL3) stock is a Buy with a A$0.40 price target. To see the full list of analyst forecasts on AML3D Ltd stock, see the AU:AL3 Stock Forecast page.
AML3D Limited has released a disclaimer regarding the information contained in its presentation, emphasizing that the data has not been audited or verified. The company disclaims any liability for inaccuracies or omissions in the presentation and clarifies that it does not constitute an offer or recommendation to purchase securities. This announcement underscores AML3D’s cautious approach to communicating financial and operational projections, potentially impacting stakeholder expectations and market perception.
The most recent analyst rating on (AU:AL3) stock is a Buy with a A$0.40 price target. To see the full list of analyst forecasts on AML3D Ltd stock, see the AU:AL3 Stock Forecast page.
AML3D Limited announced significant progress in its ‘US Scale-up’ strategy, highlighted by the opening of a fully operational US Technology Centre in Stow, Ohio, to meet the demand from the US defence sector. The company received a Letter of Intent from the US Navy for up to 100 additive manufacturing systems and 1,600 components by 2030, and delivered its first ARCEMY® X system to the Tennessee Valley Authority, marking expansion beyond defence. Additionally, AML3D secured its first UK defence contract with BAE Systems and plans to establish a European Technology Centre to support its growth strategy in the UK and Europe. The company is investing AU$12 million to double its US manufacturing capacity and has set up distribution agreements to leverage opportunities in European markets.
The most recent analyst rating on (AU:AL3) stock is a Buy with a A$0.40 price target. To see the full list of analyst forecasts on AML3D Ltd stock, see the AU:AL3 Stock Forecast page.
AML3D Limited reported a quarterly revenue of A$2.5 million and highlighted significant growth opportunities within the U.S. Navy Maritime Industrial Base, supported by a Letter of Intent forecasting a demand for their ARCEMY® systems. The company secured an initial A$4.5 million order from Huntington Ingalls Industries, marking progress in converting this opportunity into sales. Additionally, AML3D is expanding its distribution capabilities in the U.K. and Europe, with plans to establish a European facility to meet growing demand. The company is also enhancing its U.S. operations by increasing ARCEMY® systems at its Technology Centre in Ohio and fulfilling orders for the U.S. Navy’s Additive Manufacturing Centre of Excellence.
The most recent analyst rating on (AU:AL3) stock is a Buy with a A$0.40 price target. To see the full list of analyst forecasts on AML3D Ltd stock, see the AU:AL3 Stock Forecast page.
AML3D Limited has secured a significant order worth approximately $4.5 million for two custom ARCEMY® systems from Newport News Shipbuilding, a division of HII, the largest military shipbuilder in the United States. This order marks the 9th and 10th ARCEMY® systems deployed to support the U.S. Navy’s Maritime Industrial Base, further solidifying AML3D’s presence in the defense sector. The integration of AML3D’s advanced additive manufacturing technology by HII aims to reduce lead times and offer alternatives to traditional manufacturing techniques, enhancing AML3D’s positioning in the U.S. and potentially expanding its footprint into European defense markets.
The most recent analyst rating on (AU:AL3) stock is a Buy with a A$0.40 price target. To see the full list of analyst forecasts on AML3D Ltd stock, see the AU:AL3 Stock Forecast page.
AML3D Ltd has announced the quotation of nearly 4 million fully paid ordinary securities on the Australian Securities Exchange (ASX) under the code AL3. This move is part of the company’s strategy to enhance its capital structure and potentially expand its market presence, reflecting its ongoing growth and development in the advanced manufacturing sector.
The most recent analyst rating on (AU:AL3) stock is a Buy with a A$0.40 price target. To see the full list of analyst forecasts on AML3D Ltd stock, see the AU:AL3 Stock Forecast page.